Renal Cell Carcinoma

Showing NaN - NaN of 65

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

Terminated
  • Advanced Renal Cell Carcinoma
  • +2 more
  • Standard Treatment
  • AGS-003
  • Scottsdale, Arizona
  • +124 more
Jun 13, 2018

Renal Cell Carcinoma Trial in Chapel Hill, Houston (Pazopanib)

Completed
  • Renal Cell Carcinoma
  • Chapel Hill, North Carolina
  • +1 more
Mar 27, 2018

Renal Cell Carcinoma, Mantle-Cell Lymphoma, Diffuse, Large B-Cell, Lymphoma Trial in United States (SGN-CD70A)

Completed
  • Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
  • +16 more
Apr 18, 2018

Renal Cell Carcinoma, Kidney Cancer Trial in United States (Iodine (124I) Girentuximab)

Withdrawn
  • Renal Cell Carcinoma
  • Kidney Cancer
  • Iodine (124I) Girentuximab
  • Los Angeles, California
  • +7 more
Dec 20, 2017

Renal Cell Carcinoma, Kidney Cancer Trial in Houston (Capecitabine, Gemcitabine, Bevacizumab)

Completed
  • Renal Cell Carcinoma
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 21, 2017

Primary Liver Cancer, SCLC, Lymphoma Trial in Korea, Republic of, United States (MRX34)

Terminated
  • Primary Liver Cancer
  • +6 more
  • Scottsdale, Arizona
  • +9 more
Sep 26, 2016

Renal Cell Carcinoma Trial in Houston (Pemetrexed, Gemcitabine)

Terminated
  • Renal Cell Carcinoma
  • Houston, Texas
    UT MD . Anderson Cancer Center
Apr 16, 2013

Kidney Cancer, Renal Cell Carcinoma Trial in Houston (Zoledronate, Atorvastatin)

Completed
  • Kidney Cancer
  • Renal Cell Carcinoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 13, 2013

Renal Cell Carcinoma Trial in Houston (autologous human tumor-derived HSPPC-96)

Terminated
  • Renal Cell Carcinoma
  • autologous human tumor-derived HSPPC-96
  • Houston, Texas
    (unnamed)
Sep 6, 2012

Renal Cell Carcinoma Trial in Worldwide (autologous human tumor-derived HSPPC-96)

Completed
  • Renal Cell Carcinoma
  • autologous human tumor-derived HSPPC-96
  • Anchorage, Alaska
  • +75 more
Sep 6, 2012

Renal Cell Carcinoma Trial in Omaha, Hackensack, Houston (EC90 (KLH-FITC), GPI-0100, EC17 (Folate-FITC))

Terminated
  • Renal Cell Carcinoma
  • EC90 (KLH-FITC)
  • +4 more
  • Omaha, Nebraska
  • +2 more
Mar 5, 2012

Von Hippel-Lindau Syndrome, Renal Cell Carcinoma, Hemangioblastoma Trial in Houston (SU011248)

Terminated
  • Von Hippel-Lindau Syndrome
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 23, 2012

Renal Cell Carcinoma Trial in Houston (Decitabine, Interferon Alfa-2b)

Terminated
  • Renal Cell Carcinoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 22, 2011

Renal Cell Carcinoma Trial in United States (tivozanib (AV-951) plus temsirolimus)

Completed
  • Renal Cell Carcinoma
  • tivozanib (AV-951) plus temsirolimus
  • Los Angeles, California
  • +4 more
Sep 30, 2011